At the forefront of therapies for rare and orphan diseasesTM
HOME CONTACT US         
Share
about us| programs| science & technology | patient advocacy | clinical studies | investors | collaborations | news & events
 
Investors
 



Home >> Investor Relations >> Corporate Governance >> Insider Transactions

Insider Transactions

Date Name Title Type Shares Traded Price Range Sorted Descending
Jun 19, 2008 patterson matthew r Officer Automatic Sell 400 11.02 - 11.11
Apr 3, 2008 crowley john f Officer Automatic Sell 1,800 11.00 - 11.06
Apr 1, 2008 palling david Officer Automatic Sell 1,250 11.00 - 11.25
Jun 17, 2008 patterson matthew r Officer Automatic Sell 1,800 11.00 - 11.20
Jun 18, 2008 patterson matthew r Officer Automatic Sell 1,500 10.95 - 11.12
Jun 27, 2007 topper james n Director Buy 52,788 10.95 - 11.23
Jul 2, 2008 crowley john f Officer Automatic Sell 3,000 10.92 - 11.13
Apr 2, 2008 crowley john f Officer Automatic Sell 5,800 10.86 - 11.25
Apr 1, 2008 crowley john f Officer Automatic Sell 2,400 10.83 - 11.29
Jul 1, 2008 dentzer james e Officer Disposition (Non Open Market) 220 10.81
May 1, 2008 dentzer james e Officer Disposition (Non Open Market) 220 10.81
Oct 17, 2008 bloch stephen m Director Automatic Sell 3,000 10.75
Apr 14, 2008 patterson matthew r Officer Automatic Sell 500 10.74 - 10.76
Oct 20, 2008 patterson matthew r Officer Automatic Sell 2,000 10.73 - 11.51
Jul 3, 2008 crowley john f Officer Automatic Sell 1,500 10.73 - 11.03
Jul 7, 2008 crowley john f Officer Automatic Sell 2,200 10.69 - 11.26
Jul 15, 2009 crowley john f Officer Automatic Sell 6,500 10.69
Jul 1, 2008 crowley john f Officer Automatic Sell 3,300 10.62 - 10.79
Oct 20, 2008 bloch stephen m Director Automatic Sell 3,000 10.59
Nov 4, 2008 bloch stephen m Director Automatic Sell 3,800 10.54
Showing 121-140 of 392 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Amicus Therapeutics, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.


Copyright © 2012 Amicus Therapeutics, Inc. All rights reserved.   Terms of Use | Privacy Policy